How Rising Input Costs Are Reshaping UK Healthcare Procurement in 2025

Throughout 2025 NHS procurement teams have faced one of the most complex cost environments in recent years. Inflation has eased from its peak, but many of the underlying input costs for healthcare suppliers have continued to rise. This has created significant pressure on medical manufacturers, distributors and ultimately on procurement teams attempting to secure value while maintaining resilience.

Persistent cost pressures across key inputs

Raw material prices for plastics, steel and chemical reagents have remained high due to ongoing supply constraints and global demand shifts. Even when headline inflation slowed the underlying manufacturing inputs used in medical devices and consumables did not always follow the trend. Suppliers have reported higher production costs and increased volatility in demand planning which has filtered into tender pricing and contract renewals in 2025.

Energy costs have also contributed to ongoing pressures. Sterilisation processes controlled manufacturing environments and logistics all rely heavily on electricity and gas. Although energy markets stabilised compared to the previous two years the overall cost base remains materially higher than before 2020. This has directly affected the cost structure of products ranging from surgical packs to diagnostic equipment.

Supply chain resilience remains expensive

A major trend in 2025 has been the shift from least cost supply chains to resilient supply chains. More suppliers are maintaining additional safety stock dual sourcing critical inputs or expanding UK based warehousing to reduce exposure to international delays. These resilience measures offer genuine reliability benefits but they also increase operating expenses. Procurement teams have had to balance cost savings with the need for continuity especially in clinical categories where stockouts have serious consequences.

In parallel global freight capacity has improved but prices for container shipping and specialist cold chain services remain above historic levels. Even when product pricing stays stable the landed cost of delivering goods into NHS hospitals can be meaningfully higher than anticipated at the tender stage.

Greater focus on total cost rather than unit price

In response to these pressures many NHS organisations have shifted towards a more holistic view of cost. Rather than focusing solely on unit price procurement teams are increasingly evaluating total cost of ownership. This includes durability maintenance requirements energy consumption supply reliability and the administrative burden of managing multiple suppliers.

Frameworks and long term agreements have also gained renewed importance. By securing multi year volume commitments trusts often gain better price stability and improved supplier engagement. These arrangements provide manufacturers with clearer forecasting which helps offset cost volatility in their own supply chains.

The outlook for 2026

Looking forward the cost environment is expected to remain mixed. Some material inputs may soften but labour energy and regulatory compliance costs are likely to remain high. For NHS procurement teams the challenge will be maintaining value while navigating a supplier landscape still working through several years of structural cost increases.

What is clear is that procurement decisions in 2026 will require a deeper understanding of supplier cost drivers than in the past. Teams that develop strong market insight and maintain close supplier communication will be best positioned to secure quality competitive pricing and supply resilience despite the ongoing pressures.

Next
Next

UK Healthcare M&A in 2025 — Key Trends and What They Mean